Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bristol-Myers, AstraZeneca expand diabetes drug Onglyza label
The renal study evaluated the safety and efficacy of Onglyza in patients with moderate to severe renal impairment or end-stage renal disease (ESRD). The 12-week data revealed that
The renal study evaluated the safety and efficacy of Onglyza in patients with moderate to severe renal impairment or end-stage renal disease (ESRD). The 12-week data revealed that
CARBOGEN is owned by Dishman Pharmaceuticals and Chemicals of Ahmadabad, India. CARBOGEN, which has approximately 350 employees in Switzerland, is taking this step on the grounds of the
The last patient has been treated with the company’s proprietary photosensitiser Amphinex used in combination with the cytotoxic agent bleomycin at University College Hospital (UCH) in London. Principal
The DSMB concluded that the studies may continue without protocol modification, and that no other formal meetings of the DSMB are needed. The DSMB reviewed safety data from
Votrient is a targeted oral treatment, which is an effective first-line treatment for advanced renal cell carcinoma (as acknowledged by NICE) since it slows down progression of the
The approval includes two additional Agilent Microarray scanners and two Agilent Bioanalyzers, increasing aboratory capacity to handle the increasing number of MammaPrint, TargetPrint and BluePrint test requests. The
The report is based on a US survey of 100 rheumatologists and 20 MCO pharmacy directors. The report reveals that the surveyed rheumatologists expect a significant reduction in
In the Phase 2 portion of the trial, the company will compare treatment with IPI-926 in combination with gemcitabine to treatment with placebo and gemcitabine. The primary endpoint
The idea is to expedite the execution of Elan‘s clinical programs on a global scale keeping in mind the advancement, progression and execution of Elan’s development portfolio. PPD
The PFPT is the latest innovation in the company’s portfolio of preservative free pharmaceutical spray pumps (PFP), and is a combination of a chemical preservatives-free formulation, a pump